Stock ADXN ADDEX THERAPEUTICS LTD
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Market Closed - Swiss Exchange
Other stock markets
 11:30:42 2024-05-31 am EDT 		5-day change 1st Jan Change
0.0716 CHF +4.99% Intraday chart for Addex Therapeutics Ltd +3.47% +55.65%
May. 08 Addex to Present at BioEURquity Europe 2024 DJ
Apr. 30 European Equities Traded in the US as American Depositary Receipts Decline MT

Evolution of the average Target Price on Addex Therapeutics Ltd

Price target over the last 5 years

History of analyst recommendation changes

e536de51e8a4a12208f322.tZm1vWRY0O1i6-zk0Gnk_nhdxDh6lDUsJ0lCBpnDBS4.2eOCiDNu5qJPhJmziQyxlhUrkAwO-VBvcREYb9KqaX7f4eP7Jza52CfTvQ~637aacb6ad7d31581e12e09ff3671c4f

Analyst Recommendations on Addex Therapeutics Ltd

Addex to Present at BioEURquity Europe 2024 DJ
HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy MT
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate DJ
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate CI
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating MT
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating MT
ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target MT
Addex Therapeutics : Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM GL
Addex Therapeutics : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
0.0716 CHF
Average target price
0.16 CHF
Spread / Average Target
+123.46%
High Price Target
0.16 CHF
Spread / Highest target
+123.46%
Low Price Target
0.16 CHF
Spread / Lowest Target
+123.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Addex Therapeutics Ltd

HC Wainwright

Ratings for Addex Therapeutics Ltd

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ADXN Stock
  4. Consensus Addex Therapeutics Ltd